• UCLA Health
  • myUCLAhealth
  • School of Medicine
Rao Lab

The Rao Lab

Rao Lab
  • Announcement and Positions
  • Research Overview
    • Single Cell Studies of microRNA function
    • RNA binding proteins in hematopoiesis
    • microRNAs in oncogenic pathways
    • Long non-coding RNA in leukemia
    • Hematopoietic roles of microRNA
  • News
  • Publications
  • Acknowledgements
  • Personnel
    • Namita Raghavan
    • Justin Wang
    • Amit Kumar
    • Jennifer King
    • Jaspal Bassi
    • May Paing
    • Dinesh Rao, MD, PhD
    • Tiffany Tran
    • Alumni
  • UCLA Health
  • myUCLAhealth
  • School of Medicine

The Rao Lab

Research Overview

Research Overview

Research Overview

  • Single Cell Studies of microRNA function
  • RNA binding proteins in hematopoiesis
  • microRNAs in oncogenic pathways
  • Long non-coding RNA in leukemia
  • Hematopoietic roles of microRNA
  • Single Cell Studies of microRNA function
  • RNA binding proteins in hematopoiesis
  • microRNAs in oncogenic pathways
  • Long non-coding RNA in leukemia
  • Hematopoietic roles of microRNA
  1. Home
  2. Rao Lab
  3. Research Overview
  4. RNA binding proteins in hematopoiesis

RNA binding proteins in hematopoiesis

Share this

Developmental processes occur as a result of coordinated changes in gene expression, and dysregulated gene expression is at the heart of oncogenic transformation. Simplistically, gene expression can be regulated transcriptionally, at the level of chromatin and transcription factors, and post-transcriptionally, at the level of ribonucleic acid (RNA). The latter element of regulation is now understood to be highly complex and dynamic, and involves the interplay of sequences intrinsic to the regulated RNA molecules and extrinsic factors such as RNA binding proteins (RBPs), microRNAs, and other non-coding RNAs. RBPs have recently emerged as key regulators of post-transcriptional gene regulation, and as such, are likely to have quintessential roles in development and disease. The key to understanding the mechanisms of RBP regulation lies in assessment of the RNA binding repertoires of these RBPs, and meticulously connecting such data to specific points in development and oncogenesis.

Insulin like growth factor 2 mRNA binding protein 3 (IGF2BP3) is an oncofetal RBP with roles in mRNA translation, stabilization and localization. In an effort to understand post-transcriptional regulation of oncogenesis in the B-cell lineage, we undertook a study in B-lymphoblastic leukemia (B-ALL), finding upregulation of IGF2BP3 in cases that carry a translocation of the BLL gene, which portends a bad prognosis. Interestingly, it is dynamically expressed during B-cell development, suggesting a developmental function, and knockdown of IGFBP3 causes decreased growth in B-ALL cell lines. We are currently characterizing the role of this protein in hematopoeitic development and disease.

Like Us on Facebook Follow Us on Twitter Subscribe to Our Videos on YouTube Follow us on Instagram Connect with Us on LinkedIn Follow us on Pinterest
UCLA Health hospitals ranked best hospitals by U.S. News & World Report
  • UCLA Health
  • School of Medicine
  • School of Nursing
  • UCLA Campus
  • Directory
  • Newsroom
  • Publications
  • Giving
  • Careers
  • Volunteer
  • Privacy Practices
  • Nondiscrimination
  • Emergency
  • Smoke-Free
  • Terms of Use
  • 1-800-UCLA-MD1
  • Maps & Directions
  • Contact Us
  • Report Broken Links
  • Sitemap
Like Us on Facebook Follow Us on Twitter Subscribe to Our Videos on YouTube Follow us on Instagram Connect with Us on LinkedIn Follow us on Pinterest

Sign in to myUCLAhealth

Forgot USERNAME?
Forgot PASSWORD?
  • Learn more about myUCLAhealth
  • Sign Up for an Account